Cargando…
NRF2 connects Src tyrosine kinase to ferroptosis resistance in glioblastoma
Glioblastoma is a severe brain tumor characterized by an extremely poor survival rate of patients. Glioblastoma cancer cells escape to standard therapeutic protocols consisting of a combination of ionizing radiation and temozolomide alkylating drugs that trigger DNA damage by rewiring of signaling p...
Autores principales: | Cirotti, Claudia, Taddei, Irene, Contadini, Claudia, Di Girolamo, Claudia, Pepe, Gerardo, De Bardi, Marco, Borsellino, Giovanna, Helmer-Citterich, Manuela, Barilà, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Life Science Alliance LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599979/ https://www.ncbi.nlm.nih.gov/pubmed/37879937 http://dx.doi.org/10.26508/lsa.202302205 |
Ejemplares similares
-
SRC Kinase in Glioblastoma: News from an Old Acquaintance
por: Cirotti, Claudia, et al.
Publicado: (2020) -
Caspase-8 and Tyrosine Kinases: A Dangerous Liaison in Cancer
por: Contadini, Claudia, et al.
Publicado: (2023) -
Caspase-8: A Novel Target to Overcome Resistance to Chemotherapy in Glioblastoma
por: Fianco, Giulia, et al.
Publicado: (2018) -
Identification and Biological Characterization of the Pyrazolo[3,4-d]pyrimidine Derivative SI388 Active as Src Inhibitor
por: Contadini, Claudia, et al.
Publicado: (2023) -
mTOR Inhibition Leads to Src-Mediated EGFR Internalisation and Degradation in Glioma Cells
por: Colella, Barbara, et al.
Publicado: (2020)